Foment Bio

Overview

Transient Gene Therapy For Microvascular Restoration. Foment Bio's off-the-shelf gene constructs activate in vivo regenerative exosome production to renew microvasculature, resolve inflammation & restore tissue function.

Funding and backers

Total raised
$543k
1 round on record
Latest round
$543k
Venture round · May 2024 · 2 yr ago
The money's age
Long since its last round
29 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 31, 2024 Raised a round Venture round $543k · SEC Form D 2023 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round May 2024 $543k — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Foment Bio, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Ben ChlebinaExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Techstars
backs Restore Vision const embeddedUl = document
GV
backs RhyGaze
ARCH Venture Partners
backs RhyGaze
F-Prime Capital
backs Ensoma
Sofinnova Partners
backs Borea Therapeutics
JIC Venture Growth Investments
backs Restore Vision const embeddedUl = document
Similar startupsby what they do, their industry and backers
RhyGaze
GENE THERAPY.FOR SIGHT.. L E A R N M O R E.
Restore Vision const embeddedUl = document
Restore Vision is a startup based in Japan aiming to develop a visual restoration gene therapy.
EnsomaVenture round $53M · 13 mo ago · Founded 2019
The future of medicine lies within us.. Our technology platform enables in vivo engineering of hematopoietic stem cells (HSCs). It combines…
GeneVentiv TherapeuticsVenture round $1.4M · 4 yr ago · Founded 2020 · 11-50 employees
GeneVentiv Therapeutics — advancing gene therapy approaches.
DeepEn GmbHVenture round · 22 mo ago · Founded 2024 · 1-10 employees
DeepEn One™ in vivo Microendoscopy Platform. Single-Fibre Endoscope for High-Resolution In Vivo Bioimaging.
CorflowVenture round $48.5M · 2 yr ago · 51-200 employees
CoFI System Learn More CoFI System Learn More What is the importance of identifying and addressing microvascular disease, and specifically…

Financials

Total raised
$543k
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $543k Details

People

Ben Chlebina
Executive Officer
SEC Form D
Marc Penn
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Montgomery United States
HQ